The Vovk Family Business Introduces Its International Supervisory Board to Steer Global Expansion
Kormotech and Enzym Group—owned by the Vovk family—introduce their newly established International Supervisory Board, bringing global authorities together in corporate governance, innovation, supply chain, reputation strategy, and commercial leadership.
The Board’s role is to provide long-term strategic guidance to both companies, grounded in global expertise, accountability, and a shared vision for sustainable international growth. Launched in early 2024, the Board consists of five independent members who serve in non-operational, strategic advisory roles, alongside four representatives from the Vovk family.
Board Composition
- Peter Therman — Chairman of the Board
Vice Chairman of Hartwall Capital and a sixth-generation member of one of Finland’s most prominent business families, Peter Therman, brings a wealth of experience in family governance, investment oversight, and board leadership. He has served on the SecuryCast Oy, Stockmann, Camfil, and the Finnish Family Business Network boards. He is widely regarded for his ability to bridge family values with future-focused business strategy.
- Dr. Steffen Ernst — Innovation & Biotech Commercialization
A recognized pioneer in biotechnology and enzyme innovation, Dr. Steffen Ernst spent over two decades at Novozymes, where he held senior roles in global R&D and commercial development. He led the creation of Novozymes’ probiotic business through alliances with Bayer Animal Health, Adisseo, and Boehringer Ingelheim, scaling it into a global growth driver. A graduate of M.I.T. and co-founder of GreenSage Innovations, Dr. Ernst sits at the intersection of science, sustainability, and market impact, bringing world-class expertise in turning advanced biotech into a scalable business.
- Peter Ernsting — Supply Chain & Operational Excellence
With a distinguished career at Unilever, Carlsberg, and Accell Group, Peter Ernsting has led complex global supply chains, transformed operational models, and embedded sustainability into core business systems. His leadership of Carlsberg’s global operations team of 18,000 across 40 markets positions him as an invaluable guide for Vovk’s next phase of manufacturing and logistics development.
- Alison Potts — Commercial & Marketing Leadership
Appointed to the Board in March 2025, Alison Potts brings over 35 years of leadership across global sales, finance, and marketing functions. Previously, she has held executive roles at Stella & Chewy's, Nestlé Health Science, Kraft, Diageo, Bacardi, and Cisco Brewers. She holds an MBA from the Jack Welch College of Business and is an alumna of the London Business School Executive Program. Known for bridging commercial discipline with creative brand building, she has shaped go-to-market strategies and launched award-winning consumer products globally. Her expertise will guide the Vovk Family’s customer focus and global expansion strategy.
- Nataliia Popovych — Ethics, Trust & Reputation Strategy
Founder of One Philosophy and co-founder of the Resilient Ukraine CSO, Nataliia Popovych is a voice in values-based leadership, strategic communications, and crisis resilience. Named to the ICCO Hall of Fame, she has advised governments, NGOs, and global corporations on strengthening public trust and social impact. Her guidance, based on over 20 years of experience working in Ukraine and the region, the USA, and Denmark, will ensure that Vovk’s growth is deeply rooted in responsibility, transparency, and societal contribution.
- Olena Vovk — Chair of the Supervisory Board, Enzym Group
As co-owner of Enzym Group and Kormotech, Olena Vovk leads the transformation of Enzym Group from a yeast plant into one of Eastern Europe’s most resilient biotech companies. Since 2014, she has guided the company’s strategic shift toward innovation, science, and global markets. Olena sits on the academic and strategic boards of UCU Business School, shaping the next generation of ethical leadership in Ukraine.
- Rostyslav Vovk — Chair of the Supervisory Board & CEO, Kormotech
As CEO of Kormotech, Rostyslav Vovk has scaled the company from a family startup into a top-50 global pet food producer. Under his leadership, Kormotech operates in five countries with a team of over 1,300 people. He is also a board member at Enzym Group and SUP, and co-founder of initiatives like Animal ID and Patron Pets Center in Ukraine.
- Yuliana Volk — Strategic Development, Kormotech Family Representative on the Global Board
With a background in FMCG, hospitality, and media, Yuliana Vovk plays a key role in Kormotech’s global expansion. She led the company’s U.S. market entry, established its European presence, and drove its internal transformation into an English-speaking, export-focused business. As a member of the M&A and Art Direction Committees, Yuliana brings a strategic and brand-forward mindset to the Vovk Family Business portfolio.
- Andriy Tsehelyk — CEO, Enzym Group, Family Representative on the Global Board
A longtime financial advisor to the Vovk Family Business and CEO of Enzym Group since 2018, Andriy Tsehelyk has played a pivotal role in transforming the company during the crisis. He built Enzym Group’s financial system from the ground up, led investment strategy, and ensured business continuity through blackouts and full-scale war. Thanks to his foresight and leadership, the company grew revenues by nearly 30% in 2022 while keeping operations fully active.
Leading with Purpose, Scaling with Integrity
The Vovk Family Business is entering a new phase of growth — expanding into Asia, the EU, the U.S., and Africa, launching products not yet available on the Ukrainian market, increasing production capacity, and scaling biotech R&D. Kormotech is scaling its global presence, with a strategic focus on the CEE region, increasing production capacity, and aiming to join the world’s top 30 pet food producers by 2029. The companies are building strong teams and a system of external strategic oversight guided by global experience to support this transformation.
The new International Board reflects the family’s ambition to grow responsibly while staying rooted in long-term vision and values. With expertise in biotechnology, operations, stakeholder trust, and commercial strategy, the Board will help shape a resilient, future-ready business capable of navigating uncertainty and thriving beyond it.